Drug Profile
AC 103
Alternative Names: AC-103 - AbClon; AC103Latest Information Update: 04 Sep 2023
Price :
$50
*
At a glance
- Originator AbClon
- Class Antibodies; Antineoplastics
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Discontinued Colorectal cancer; Lung cancer
Most Recent Events
- 04 Sep 2023 Discontinued - Preclinical for Colorectal cancer in South Korea (unspecified route)
- 04 Sep 2023 Discontinued - Preclinical for Lung cancer in South Korea (unspecified route)
- 28 Jul 2020 No recent reports of development identified for preclinical development in Colorectal-cancer in South Korea